I like the direction, and the science. There are many drugs that people need to counteract the side effects by taking extra vitamins/supplements due to the deterioration of either bone marrow, calcium and many other things. Simply, the doctors prescribing need to have the knowledge base to begin with. The drug book is ALWAYS behind by at least a year. Going through some of the meds I was taking some time ago the doc was reading the benefits vs. the adverse effects for the possibility one was causing the symptoms I had. On and on and on lemme tell ya. Turned out none of them related but there were CERTAINLY some deficiencies I wasn't told to counter with other vitamins.

Focusing on just the technical side for a moment, I like the potential upward movement but still see a bit of consolidation first. There is a handful of pumpers on the ihub board that just keep on pushing. Science wins in the end and this has excellent potential throughout 2016. Not telling anyone how to trade this but for me, it's hold/accumulate .80 - 1.10. Once the trial is fully loaded and trickles data I doubt this will be sitting at this level long. My strategy is sell on the runs but to maintain a core leaving enough to make a difference. This is still relatively new to the investor base imo but starting to get noticed. Nice grant support certainly helps.